David Paling

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial

Rhian Raftopoulos, Simon J. Hickman, Ahmed Toosy et al. · The Lancet Neurology · 2016 · 194 citations · Full text

Acute Optic Neuritis, Ocular Disease, Ophthalmology +10

Sodium accumulation is associated with disability and a progressive course in multiple sclerosis

David Paling, Bhavana Solanky, Frank Riemer et al. · Brain · 2013 · 122 citations · Full text

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation

Emma Tallantyre, Dan Whittam, Stephen Jolles et al. · Journal of Neurology · 2018 · 82 citations · Full text

Cerebral Arterial Bolus Arrival Time is Prolonged in Multiple Sclerosis and Associated with Disability

David Paling, Esben Thade Petersen, Daniel J. Tozer et al. · Journal of Cerebral Blood Flow & Metabolism · 2013 · 69 citations · Full text

Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting

Lorenza Angelini, William Hodgkinson, Craig Smith et al. · Journal of Neurology · 2020 · 63 citations · Full text